---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-128901"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T02:58:27.634603+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics cuts workforce by 23% (5 employees) to preserve capital

## Summary
- Board approved reduction of 5 employees (~23% of headcount) on Dec 10; effective Dec 13.
- Estimated restructuring charges of ~$0.3 million for severance, benefits, and related costs.
- Majority of cash payments expected to be substantially complete by end of Q3 2025.
- Severance contingent on release of claims; includes COBRA premiums for specified period.

## SEC filing metadata
- accession: 0001104659-24-128901
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465924128901/0001104659-24-128901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465924128901/tm2431046d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-128901
- JSON: https://secwatch.observer/filing/0001104659-24-128901.json
- Plain text: https://secwatch.observer/filing/0001104659-24-128901.txt

## Key facts
- Restructurings & Charges
  Outlook Therapeutics, Inc. announced a restructuring with charges of approximately $ 0.3 million (5 people, or approximately 23% of the Company’s existing headcount).
  - Type: restructuring
  - Charge: approximately $ 0.3 million
  - Headcount: 5 people, or approximately 23% of the Company’s existing headcount
  source text: eligibility for severance benefits is contingent upon execution of a general release of claims against the Company. The Company estimates that it will incur approximately $ 0.3 million in restructuring charges in connection with the workforce reduction, consisting of cash-based expenses related to employee severance and notice period payments, benefits and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649989/000110465924128901/0001104659-24-128901-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.